CLINICAL TRIALS for Prostate Cancer

Treatment
CLINICAL TRIALS
http://www.pcf.org/site/c.leJRIROrEpH/b.5849073/k.9B21/Clinical_Trials…
Clinical drug trials play a crucial role in moving new treatments to patients who need them most, securing data so regulatory approvals can be obtained and new drugs can move into widespread clinical practice. Patients who participate in clinical trials provide an invaluable service both to treatment science and fellow patients.

There are currently more than several Phase III drug trials and more than 90 Phase I/II trials in process for prostate cancer in North America and Europe. Those that are approved will join the five new drugs that have been approved for men with advanced metastatic disease in the past two years and further improve outcomes for patients:

Jevtana (cabazitaxel)

Provenge (sipuleucel-T)

Xgeva (denusomab)

Xofigo (radium 223 dichloride)

Xtandi (enzalutimide)

Zytiga (abiraterone)

The resources on this page can direct you to clinical trials that are currently open for enrollment in your local area, as well as across the country. If you are considering a clinical trial, speak to your doctor about the potential benefits of participating in a trial so you can make an informed decision that is best for you.